Use of immunoglobulin preparations for the manufacture of an orally administered drug for preventing hemolytic uremic syndrome

摘要

The invention relates to the use of immunoglobulin preparations with high antibody content against EHEC hemolysin and optionally against surface antigens of EHEC hemolysin gene carrying bacteria and against shiga-like toxin II for producing an oral medicament to prevent hemolytic uremic syndrome after EHEC infection and a preparation for the same. The high antibody content can be obtained by a targeted selection of individual donors or by the immunization of donor animals.